NSRX vs SGMO
Comparison between Nasus Pharma Ltd (NSRX, Company) and Sangamo Therapeutics Inc (SGMO, Company).
Both NSRX and SGMO are from the Healthcare sector.
NSRX vs SGMO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
NSRX
$29M
SGMO
$29M
Max Drawdown
Winner
NSRX
78.03%
SGMO
99.85%
Sharpe Ratio
Winner
NSRX
-0.48
SGMO
-0.77
5Y Beta
NSRX
0.69
SGMO
N/A
Industry
NSRX
Drug Manufacturers - General
SGMO
Biotechnology
P/E Ratio
Winner
NSRX
-4.94
SGMO
-0.23
Forward P/E
NSRX
N/A
SGMO
0.40
PEG Ratio
NSRX
-0.02
SGMO
N/A
5Y EPS CAGR
NSRX
N/A
SGMO
-3.12%
Debt to Equity
NSRX
0.00%
SGMO
0.00%
Free Cash Flow Yield
NSRX
-17.04%
SGMO
N/A
NSRX vs SGMO - Historical Returns
Returns include dividend reinvestment.
1M
NSRX
-6.96%
Winner
SGMO
+0.00%
3M
Winner
NSRX
+25.39%
SGMO
-44.28%
6M
Winner
NSRX
-42.58%
SGMO
-85.58%
1Y
Winner
NSRX
-61.09%
SGMO
-87.02%
5Y(CAGR)
NSRX
N/A
SGMO
-62.31%
10Y(CAGR)
NSRX
N/A
SGMO
-35.92%
Max(CAGR)
NSRX
-62.66%
Winner
SGMO
-18.29%
NSRX vs SGMO - Annual Returns (2000 - 2026)
Returns include dividend reinvestment.
| Year | NSRX | SGMO |
|---|---|---|
| 2026 | -57.48% | -83.13% |
| 2025 | +10.91% | -62.83% |
| 2024 | N/A | +83.35% |
| 2023 | N/A | -82.70% |
| 2022 | N/A | -59.85% |
| 2021 | N/A | -52.89% |
| 2020 | N/A | +90.07% |
| 2019 | N/A | -28.95% |
| 2018 | N/A | -34.59% |
| 2017 | N/A | +429.03% |
| 2016 | N/A | -65.92% |
| 2015 | N/A | -40.21% |
| 2014 | N/A | +10.30% |
| 2013 | N/A | +125.85% |
| 2012 | N/A | +103.04% |
| 2011 | N/A | -59.72% |
| 2010 | N/A | +8.14% |
| 2009 | N/A | +61.31% |
| 2008 | N/A | -72.25% |
| 2007 | N/A | +97.29% |
| 2006 | N/A | +60.98% |
| 2005 | N/A | -30.52% |
| 2004 | N/A | +9.29% |
| 2003 | N/A | +59.48% |
| 2002 | N/A | -66.14% |
| 2001 | N/A | -45.86% |
| 2000 | N/A | +29.48% |
NSRX vs SGMO Drawdown Comparison
The maximum drawdown for NSRX was -78.03%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The maximum drawdown for SGMO was -99.85%, occurring on Jun 23, 2026. This drawdown has not yet recovered.
The current NSRX drawdown is -64.92%. The current SGMO drawdown is -99.85%.
| Rank | NSRX | SGMO |
|---|---|---|
| #1 | -78.03% Dec 31, 2025 - Mar 30, 2026 | -99.85% Sep 1, 2000 - Jun 23, 2026 |
| #2 | -30.96% Aug 19, 2025 - Dec 31, 2025 | -56.01% Apr 6, 2000 - Jun 12, 2000 |
| #3 | -2.42% Aug 13, 2025 - Aug 18, 2025 | -41.46% Jul 24, 2000 - Aug 29, 2000 |
| #4 | N/A | -20.03% Jun 12, 2000 - Jun 20, 2000 |
| #5 | N/A | -15.18% Jul 11, 2000 - Jul 18, 2000 |
| #6 | N/A | -6.25% Jun 23, 2000 - Jun 27, 2000 |
| #7 | N/A | -5.08% Jul 5, 2000 - Jul 7, 2000 |
| #8 | N/A | -2.71% Jun 30, 2000 - Jul 5, 2000 |
| #9 | N/A | -0.54% Jun 28, 2000 - Jun 30, 2000 |
Correlation
Correlation between NSRX and SGMO is 0.78 which considered as a strong positive correlation - the stocks tend to move together.
0.78
-101
Select Stocks to Compare
Popular: NSRX vs SPYSGMO vs SPY
More Comparisons
Compare with similar stocks